Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Mallinckrodt
Boehringer Ingelheim
Colorcon
Harvard Business School

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

LEVOLEUCOVORIN CALCIUM Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Levoleucovorin Calcium patents expire, and what generic alternatives are available?

Levoleucovorin Calcium is a drug marketed by Actavis Llc, Amneal Pharms Co, Nanjing King-friend, West-ward Pharms Int, Gland Pharma Ltd, Ingenus Pharms Llc, Mylan Teoranta, and Sandoz Inc. and is included in eleven NDAs.

The generic ingredient in LEVOLEUCOVORIN CALCIUM is levoleucovorin calcium. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the levoleucovorin calcium profile page.

Drug patent expirations by year for LEVOLEUCOVORIN CALCIUM
Recent Clinical Trials for LEVOLEUCOVORIN CALCIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Phoenix Children's HospitalPhase 2
United States Department of DefensePhase 2
Autism SpeaksPhase 2

See all LEVOLEUCOVORIN CALCIUM clinical trials

Recent Litigation for LEVOLEUCOVORIN CALCIUM

Identify potential future generic entrants

District Court Litigation
Case NameDate
Spectrum Pharmaceuticals, Inc v. Sandoz Inc.2015-03-03
Spectrum Pharmaceuticals, Inc. v. Eurohealth International Sarl2014-06-18
Spectrum Pharmaceuticals Inc v. InnoPharma Inc.2012-03-02

See all LEVOLEUCOVORIN CALCIUM litigation

Pharmacology for LEVOLEUCOVORIN CALCIUM
Drug ClassFolate Analog
Medical Subject Heading (MeSH) Categories for LEVOLEUCOVORIN CALCIUM
Paragraph IV (Patent) Challenges for LEVOLEUCOVORIN CALCIUM
Tradename Dosage Ingredient NDA Submissiondate
FUSILEV POWDER;INTRAVENOUS levoleucovorin calcium 020140 2013-12-19
FUSILEV SOLUTION;INTRAVENOUS levoleucovorin calcium 020140 2013-12-19
FUSILEV SOLUTION;INTRAVENOUS levoleucovorin calcium 020140 2011-10-26
FUSILEV POWDER;INTRAVENOUS levoleucovorin calcium 020140 2011-10-26

US Patents and Regulatory Information for LEVOLEUCOVORIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Llc LEVOLEUCOVORIN CALCIUM levoleucovorin calcium POWDER;INTRAVENOUS 206516-001 Feb 13, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Gland Pharma Ltd LEVOLEUCOVORIN CALCIUM levoleucovorin calcium SOLUTION;INTRAVENOUS 210892-001 Sep 14, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Nanjing King-friend LEVOLEUCOVORIN CALCIUM levoleucovorin calcium POWDER;INTRAVENOUS 211003-001 Aug 22, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
McKesson
Harvard Business School
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.